, /PRNewswire/ -- J INTS BIO announced that it held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' on the sideline of the 2022 IASLC World Conference on Lung Cancer held in Vienna, Austria, on 7th August. This followed the 2 successful focus group meetings conducted during ASCO in June. J INTS BIO established this Global Advisory Board to provide expert advice and support for its clinical development program. In attendance were Prof.